These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 682632)

  • 1. Specific progesterone receptor in human renal cancer.
    Concolino G; Marocchi A; Tenaglia R; Di Silverio F; Sparano F
    J Steroid Biochem; 1978 May; 9(5):399-402. PubMed ID: 682632
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestational therapy in human renal carcinoma and steroid receptors.
    Concolino G; Marocchi A; Di Silverio F; Conti C
    J Steroid Biochem; 1976; 7(11-12):923-7. PubMed ID: 1025371
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of (3H)R5020 to progesterone receptor and serum contaminants in human endometrium.
    Barile G; Sica G; Corradini M; Iacobelli S
    Eur J Obstet Gynecol Reprod Biol; 1979 Aug; 9(4):237-42. PubMed ID: 264090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocrine background of human renal cell carcinoma. II. Attempt to induce the R-5020-binding components by oestrogens.
    Bojar H; Maar K; Staib W
    Urol Int; 1979; 34(4):312-9. PubMed ID: 224547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [3H]progesterone and [6,7-3H]-17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione for the measurement of progesterone receptors in human malignant tissue.
    Seematter RJ; Hoffman PG; Kuhn RW; Lockwood LC; Siiteri PK
    Cancer Res; 1978 Sep; 38(9):2800-6. PubMed ID: 679186
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of progesterone receptor in human uterine cytosol with a synthetic progestin, norgestrel [proceedings].
    Srivastava AK; Habib FK; Hancock KW; Stitch SR
    J Endocrinol; 1978 May; 77(2):22P-23P. PubMed ID: 660043
    [No Abstract]   [Full Text] [Related]  

  • 7. The endocrine background of human renal cell carcinoma. III. Role of inhibitors of R 5020 binding in tumour cytosol.
    Bojar H; Maar K; Staib W
    Urol Int; 1979; 34(5):321-9. PubMed ID: 573929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of heparin with the cytosol progesterone receptor from human mammary tumours: separate estimation of the 4 and 7 S binding components with a simple dextran-charcoal assay.
    Thorsen T
    J Steroid Biochem; 1981 Feb; 14(2):221-7. PubMed ID: 7193783
    [No Abstract]   [Full Text] [Related]  

  • 9. The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosol.
    Bojar H; Maar K; Staib W
    Urol Int; 1979; 34(4):302-11. PubMed ID: 224546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in uterine cytosolic oestrogen and progesterone receptor levels during the rat oestrous cycle.
    Kielhorn J; Hughes A
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):842-50. PubMed ID: 579041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor in the rat anterior pituitary. Transformation and nuclear translocation.
    Spona J; Bieglmayer C; Pirker R
    FEBS Lett; 1979 Jan; 97(2):269-74. PubMed ID: 570129
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of the progesterone receptor in the estrogen-induced and -dependent renal tumor of the Syrian golden hamster.
    Li SA; Li JJ; Villee CA
    Ann N Y Acad Sci; 1977 Mar; 286():369-83. PubMed ID: 281185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamental study of endocrine therapy for renal cell carcinoma--progesterone and androgen receptors in normal kidneys and renal cell carcinomas (author's transl)].
    Nakano E
    Nihon Hinyokika Gakkai Zasshi; 1980 Jul; 71(7):775-87. PubMed ID: 7420805
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a progestin-binding macromolecule in the amphibian oocyte cytosol.
    Kalimi M; Ziegler D; Morrill GA
    Biochem Biophys Res Commun; 1979 Feb; 86(3):560-7. PubMed ID: 311639
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid receptors in human renal carcinoma.
    Chen L; Weiss FR; Chaichik S; Keydar I
    Isr J Med Sci; 1980 Nov; 16(11):756-60. PubMed ID: 7192273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1985 Jan; 22(1):57-62. PubMed ID: 3871881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human renal cell carcinoma as a hormone-dependent tumor.
    Concolino G; Marocchi A; Conti C; Tenaglia R; Di Silverio F; Bracci U
    Cancer Res; 1978 Nov; 38(11 Pt 2):4340-4. PubMed ID: 698974
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of progesterone binding in nuclei and cytosol of estrogen-induced adenocarcinoma cells in primary culture.
    Lin YC; Talley DJ; Villee CA
    J Steroid Biochem; 1980 Jan; 13(1):29-37. PubMed ID: 7382481
    [No Abstract]   [Full Text] [Related]  

  • 19. Estradiol and progesterone binding components in the cytosol of normal human fallopian tubes.
    Pollow K; Inthraphuvasak J; Grill HJ; Manz B
    J Steroid Biochem; 1982 Mar; 16(3):429-35. PubMed ID: 7201048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturable binding of [3H]-promegestone in sheep liver cytosol is not to receptors for progesterone or glucocorticoids.
    Sirett DA; Grant JK
    J Steroid Biochem; 1982 Apr; 16(4):553-5. PubMed ID: 7201050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.